Matches in SemOpenAlex for { <https://semopenalex.org/work/W3001901076> ?p ?o ?g. }
- W3001901076 endingPage "2729" @default.
- W3001901076 startingPage "2717" @default.
- W3001901076 abstract "Abstract Pre‐clinical studies have indicated that mitoprotective drugs may add cardioprotection beyond rapid revascularization, antiplatelet therapy and risk modification. We review the clinical efficacy of mitoprotective drugs that have progressed to clinical testing comprising cyclosporine A, KAI‐9803, MTP131 and TRO 40303. Whereas cyclosporine may reduce infarct size in patients undergoing primary angioplasty as evaluated by release of myocardial ischaemic biomarkers and infarct size imaging, the other drugs were not capable of demonstrating this effect in the clinical setting. The absent effect leaves the role of the mitochondrial permeability transition pore for reperfusion injury in humans unanswered and indicates that targeting one single mechanism to provide mitoprotection may not be efficient. Moreover, the lack of effect may relate to favourable outcome with current optimal therapy, but conditions such as age, sex, diabetes, dyslipidaemia and concurrent medications may also alter mitochondrial function. However, as long as the molecular structure of the pore remains unknown and specific inhibitors of its opening are lacking, the mitochondrial permeability transition pore remains a target for alleviation of reperfusion injury. Nevertheless, taking conditions such as ageing, sex, comorbidities and co‐medication into account may be of paramount importance during the design of pre‐clinical and clinical studies testing mitoprotective drugs." @default.
- W3001901076 created "2020-01-30" @default.
- W3001901076 creator A5004368211 @default.
- W3001901076 creator A5042601884 @default.
- W3001901076 creator A5049461964 @default.
- W3001901076 creator A5076082024 @default.
- W3001901076 creator A5086542391 @default.
- W3001901076 date "2020-01-22" @default.
- W3001901076 modified "2023-10-17" @default.
- W3001901076 title "Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction" @default.
- W3001901076 cites W110079119 @default.
- W3001901076 cites W1504822816 @default.
- W3001901076 cites W1506134312 @default.
- W3001901076 cites W1543235995 @default.
- W3001901076 cites W1606511543 @default.
- W3001901076 cites W1715909735 @default.
- W3001901076 cites W1851055496 @default.
- W3001901076 cites W1966038248 @default.
- W3001901076 cites W1976950780 @default.
- W3001901076 cites W1991911557 @default.
- W3001901076 cites W1992591882 @default.
- W3001901076 cites W1996146434 @default.
- W3001901076 cites W1999312816 @default.
- W3001901076 cites W2004046014 @default.
- W3001901076 cites W2004717100 @default.
- W3001901076 cites W2004809359 @default.
- W3001901076 cites W2004916700 @default.
- W3001901076 cites W2006279693 @default.
- W3001901076 cites W2013969090 @default.
- W3001901076 cites W2021722138 @default.
- W3001901076 cites W2022211348 @default.
- W3001901076 cites W2028934633 @default.
- W3001901076 cites W2029077404 @default.
- W3001901076 cites W2046196975 @default.
- W3001901076 cites W2046353863 @default.
- W3001901076 cites W2047577190 @default.
- W3001901076 cites W2055456981 @default.
- W3001901076 cites W2056661625 @default.
- W3001901076 cites W2057099146 @default.
- W3001901076 cites W2058128468 @default.
- W3001901076 cites W2059028511 @default.
- W3001901076 cites W2060012980 @default.
- W3001901076 cites W2060517558 @default.
- W3001901076 cites W2063099262 @default.
- W3001901076 cites W2065679608 @default.
- W3001901076 cites W2066454348 @default.
- W3001901076 cites W2073457659 @default.
- W3001901076 cites W2074800090 @default.
- W3001901076 cites W2075857100 @default.
- W3001901076 cites W2075995611 @default.
- W3001901076 cites W2077686023 @default.
- W3001901076 cites W2077691015 @default.
- W3001901076 cites W2084890658 @default.
- W3001901076 cites W2089127203 @default.
- W3001901076 cites W2096541614 @default.
- W3001901076 cites W2096986919 @default.
- W3001901076 cites W2099891423 @default.
- W3001901076 cites W2103308668 @default.
- W3001901076 cites W2104927019 @default.
- W3001901076 cites W2108994617 @default.
- W3001901076 cites W2111074523 @default.
- W3001901076 cites W2111686526 @default.
- W3001901076 cites W2117370437 @default.
- W3001901076 cites W2117911689 @default.
- W3001901076 cites W2119301730 @default.
- W3001901076 cites W2121520913 @default.
- W3001901076 cites W2122179672 @default.
- W3001901076 cites W2136009429 @default.
- W3001901076 cites W2136068202 @default.
- W3001901076 cites W2143830716 @default.
- W3001901076 cites W2145429328 @default.
- W3001901076 cites W2145611813 @default.
- W3001901076 cites W2147640676 @default.
- W3001901076 cites W2150419321 @default.
- W3001901076 cites W2151115143 @default.
- W3001901076 cites W2153298328 @default.
- W3001901076 cites W2157837017 @default.
- W3001901076 cites W2160249517 @default.
- W3001901076 cites W2160294830 @default.
- W3001901076 cites W2165248515 @default.
- W3001901076 cites W2167554601 @default.
- W3001901076 cites W2168251353 @default.
- W3001901076 cites W2176701303 @default.
- W3001901076 cites W2180073714 @default.
- W3001901076 cites W2189233989 @default.
- W3001901076 cites W2200357463 @default.
- W3001901076 cites W2202366653 @default.
- W3001901076 cites W2218863931 @default.
- W3001901076 cites W2251914552 @default.
- W3001901076 cites W2294335173 @default.
- W3001901076 cites W2326510595 @default.
- W3001901076 cites W2349946933 @default.
- W3001901076 cites W2360592203 @default.
- W3001901076 cites W2387234219 @default.
- W3001901076 cites W2473252551 @default.
- W3001901076 cites W2531885368 @default.
- W3001901076 cites W2571145562 @default.
- W3001901076 cites W2604176879 @default.